NSCIF Overview

Private Placement Completion: Nanalysis Scientific has closed the first tranche of a non-brokered private placement, raising approximately $2.5 million by issuing about 16.5 million units at $0.15 each.

Use of Proceeds: The funds raised will primarily be used for debt reduction, with plans for a second tranche expected to close in January 2026.

Increased Offering Size: Due to strong investor demand, the company has increased the offering size, allowing for an additional issuance of up to 23,333,333 units, potentially raising total gross proceeds to $3.5 million, pending TSX Venture Exchange approval.

Stock Performance: Nanalysis Scientific's stock (NSCIF) closed at $0.115, reflecting no change in value.

Financial Performance Overview: Nanalysis Scientific Corp. reported a 12% decrease in consolidated revenue for Q3 2025 compared to the previous year, primarily due to a significant drop in product sales, while security services revenue increased by 10%.

Operational Challenges and Improvements: The company faced challenges in the capital equipment market due to global trade uncertainties, but improvements in operational efficiency and management changes in the Security Services segment have led to better margins and revenue growth.

Strategic Initiatives: Nanalysis has secured a five-year OEM partnership with IMRIS and is focusing on continuous improvement initiatives, including cost reductions and restructuring its sales organization to enhance product revenue.

Future Outlook: The company anticipates ongoing macroeconomic uncertainties will affect capital equipment purchases, but it remains committed to operational discipline and margin improvement as it navigates these challenges.

Conference Call Announcement: Nanalysis Scientific Corp. will host a conference call on November 24, 2025, at 4:15 PM ET to discuss its quarterly results for the period ending September 30, 2025.

Participation Details: Investors can join the call via Zoom, with the meeting ID provided, and the webcast will be archived on the company's investor relations webpage for 90 days.

Company Overview: Nanalysis Scientific Corp. specializes in portable Nuclear Magnetic Resonance (NMR) spectrometers and operates a services division, including a significant contract with the Canadian Air Transport Security Authority for maintaining security scanners.

Forward-Looking Statements Disclaimer: The press release includes forward-looking statements that are subject to risks and uncertainties, and the company disclaims any obligation to update these statements unless required by law.

CFO Resignation: Randall McRae has resigned as Chief Financial Officer of Nanalysis Scientific Corp., effective December 5, 2025, but will remain available in an advisory role until then.

Interim CFO Appointment: Heather Kury, the Corporate Controller, will serve as the Interim Chief Financial Officer while the company searches for a permanent replacement.

Heather Kury's Background: Kury brings over twenty years of experience in corporate strategy and operational excellence, having held senior roles in the oil and gas and IT sectors.

Company Overview: Nanalysis Scientific Corp. develops portable Nuclear Magnetic Resonance (NMR) spectrometers and operates a services division, including a significant contract with the Canadian Air Transport Security Authority.

Nanalysis and Wiley Collaboration: Nanalysis Scientific Corp. announced the integration of its 1D NMR files into Wiley's KnowItAll 2026 software, allowing users to access over 1.28 million NMR spectra for enhanced data analysis and compound identification.

Enhanced Analytical Workflows: This partnership aims to simplify spectral interpretation and incorporate low-field NMR data analysis into routine laboratory workflows across various industries, including pharmaceuticals and biotechnology.

Company Overview: Nanalysis Scientific Corp. specializes in portable NMR spectrometers and MRI technology, reporting a decrease in product sales due to economic uncertainty and global tariff conditions.

Financial Performance: For Q2 2025, the company reported total revenue of $9,576,000, a 17% decline from the previous year, primarily driven by a 46% drop in product sales, while security services revenue increased by 7%.

Operational Improvements: The company has implemented cost reduction measures and efficiency improvements in its security services segment, leading to improved margins and operational effectiveness expected to continue throughout 2025.

Future Outlook: Despite challenges, Nanalysis remains focused on advancing its scientific instrumentation capabilities and enhancing service offerings, with expectations for improved margins and operational execution moving forward.